MI · State regulatory reference

Michigan.

Moderate

Michigan's telehealth provisions in the Public Health Code (MCL 333.16283, 333.16285) let a prescriber acting within scope prescribe via telehealth without a mandatory prior in-person exam, so a treatment relationship can form by synchronous telehealth; controlled substances must additionally satisfy the Code's bona-fide-relationship requirements. Compounding under Mich. Admin. Code R. 338.533 adopts USP 795 and 797 (2023 revisions) by reference. No Michigan-board enforcement specific to peptides or compounded GLP-1s was found.

Last reviewed · 2026-05-25 · verified entry

Agencies

Medical board

Michigan Medical Board

https://www.michigan.gov/lara/bureau-list/bpl/health/hp-lic-health-prof/medicine ↗

Pharmacy board

Michigan Board of Pharmacy

https://www.michigan.gov/lara/bureau-list/bpl/health/hp-lic-health-prof/pharmacy ↗

TPC notes

Telehealth

MCL 333.16285 does not require a prior in-person exam; a prescriber within scope may prescribe via telehealth, though controlled substances must meet all Public Health Code requirements and follow-up care must be provided or referred.

Compounding

Mich. Admin. Code R. 338.533 adopts USP 795 and 797 (2023) by reference; sterile-compounding 503A applicants face LARA inspection at licensure plus a USP-compliance inspection or accreditation within six months, and 503B facilities must meet 21 CFR 211 cGMP.

Sources